⌘K

Login Start Free

Home/Filings/4/0001628280-20-009548

4//SEC Filing

BROWN JAMES F 4

Accession 0001628280-20-009548

CIK 0001358403other

View on SEC.gov Company Profile

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 4:49 PM ET

Size

5.4 KB

Accession

0001628280-20-009548

Insider Transaction Report

Form 4

Period: 2020-06-15

BELLICUM PHARMACEUTICALS, INCBLCM

Director

Transactions

Award
Stock Option (right to buy)
2020-06-15+6,500→ 6,500 total
Exercise: $8.42Exp: 2030-06-14→ Common Stock (6,500 underlying)

Footnotes (1)

[F1]The shares subject to the option vest and become exercisable in full on the one-year anniversary of the grant date.

Documents

1 file

4
wf-form4_159234055419319.xmlPrimary
FORM 4

Issuer

BELLICUM PHARMACEUTICALS, INC

CIK 0001358403

Entity typeother

Related Parties

1

filerCIK 0001624379

Filing Metadata

Form type: 4
Filed: Jun 15, 8:00 PM ET
Accepted: Jun 16, 4:49 PM ET
Size: 5.4 KB

View on SEC.gov